What is the interpretation of the following pulmonary function test results: FEV1 (forced expiratory volume in 1 second)/FVC (forced vital capacity) 77%, FEV1 (forced expiratory volume in 1 second) 71% predicted, FVC (forced vital capacity) 72% predicted, SVC (slow vital capacity) 67% predicted, FEV1/SVC 83%, TLC (total lung capacity) 68% predicted, RV/TLC (residual volume/total lung capacity) 104%, DLCO (diffusing capacity of the lung for carbon monoxide) 85% predicted, VA (alveolar volume) 78% predicted, KCO (transfer coefficient) 109% predicted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mixed Ventilatory Defect with Restrictive Predominance

These pulmonary function test results demonstrate a mixed ventilatory defect, characterized by both restrictive and obstructive components, with the restrictive pattern being predominant based on the significantly reduced TLC (68% predicted).

Pattern Analysis

Restrictive Component (Primary)

  • TLC is 68% predicted (below the 5th percentile threshold), which definitively establishes restriction 1
  • FVC 72% and SVC 67% are both reduced, supporting volume loss
  • The reduced TLC confirms true restriction rather than pseudorestriction from air trapping 1

Obstructive Component (Secondary)

  • FEV1/FVC ratio of 77% is likely below the 5th percentile for most reference populations, indicating airflow obstruction 1
  • FEV1/SVC ratio of 83% further supports airflow limitation
  • RV/TLC ratio of 104% (at or slightly above upper limit of normal) suggests mild air trapping despite the restrictive process 1

Gas Exchange Pattern

  • DLCO 85% predicted shows mild reduction
  • VA 78% predicted is reduced proportionally to the restrictive defect
  • KCO 109% predicted is elevated, which is characteristic of extrapulmonary restriction or chest wall/neuromuscular disease 2

Clinical Interpretation

The elevated KCO despite reduced DLCO is the critical distinguishing feature. When DLCO is reduced but KCO is normal or elevated, this pattern typically indicates:

  1. Extrapulmonary restriction (chest wall disease, obesity, pleural disease)
  2. Neuromuscular weakness
  3. Volume loss without parenchymal destruction

The elevated KCO argues against primary parenchymal lung diseases like interstitial lung disease or emphysema, which would reduce KCO 2, 3. The mild air trapping (RV/TLC 104%) with preserved KCO suggests peripheral airway involvement without significant emphysematous destruction.

Severity Assessment

  • Moderate restriction based on TLC 68% predicted
  • Mild-to-moderate obstruction based on FEV1 71% and FEV1/VC ratios
  • Mild gas exchange impairment based on DLCO 85%

Diagnostic Considerations

The pattern most strongly suggests:

  • Primary consideration: Extrapulmonary restrictive disease (obesity hypoventilation, chest wall deformity, pleural disease) with coexistent mild airways disease
  • Alternative: Neuromuscular weakness with secondary atelectasis and airways involvement

The normal-to-elevated KCO essentially excludes primary parenchymal diseases such as interstitial lung disease, which would show reduced KCO 4, 3.

Important Caveats

  • The FEV1/FVC ratio interpretation depends on appropriate reference equations for age, sex, and ethnicity 1
  • Bronchodilator testing is essential to assess reversibility of the obstructive component 1
  • Clinical correlation with imaging (chest radiograph or CT) is mandatory to distinguish between extrapulmonary restriction, pleural disease, and parenchymal processes
  • Respiratory muscle strength testing should be considered if neuromuscular disease is suspected 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.